Prices and clinical benefit of cancer drugs in the USA and Europe: a cost–benefit analysis
Author:
Publisher
Elsevier BV
Subject
Oncology
Reference16 articles.
1. Insights into the increasing costs of cancer drugs;Bach;Clin Adv Hematol Oncol,2019
2. Price increases of protected-class drugs in Medicare Part D, relative to inflation, 2012–2017;Hwang;JAMA,2019
3. Accessibility of cancer drugs in Switzerland: time from approval to pricing decision between 2009 and 2018;Vokinger;Health Policy,2020
4. Quicktake: drug prices;Langreth,2019
5. Challenges in the design and interpretation of noninferiority trials;Mauri;N Engl J Med,2017
Cited by 143 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Cost-effectiveness of nivolumab plus gemcitabine-cisplatin as first-line treatment for advanced urothelial carcinoma in China and the United States;Frontiers in Immunology;2024-09-13
2. Impact of competition on reimbursement decisions for cancer drugs in China: an observational study;The Lancet Regional Health - Western Pacific;2024-09
3. Frequency of use and cost in Japan of first-line palliative chemotherapies for recurrent or metastatic squamous cell carcinoma of the head and neck;Japanese Journal of Clinical Oncology;2024-08-29
4. Clinical value of guideline recommended molecular targets and genome targeted cancer therapies: cross sectional study;BMJ;2024-08-20
5. Chronic myeloid leukemia: 2025 update on diagnosis, therapy, and monitoring;American Journal of Hematology;2024-08-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3